Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease

scientific article

Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0735-1097(99)00391-5
P698PubMed publication ID10551689
P5875ResearchGate publication ID12748592

P2093author name stringDawkins KD
Ward ME
Wong YK
P2860cites workDetection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.Q37886690
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteriesQ37891287
Infection with Chlamydia pneumoniae in BrooklynQ37895177
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarctionQ37899465
Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular eventsQ43429735
Chlamydia pneumoniae and atherosclerosis.Q33534714
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cellsQ35488540
The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniaeQ37230432
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS StudyQ37878753
The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgeryQ37879200
Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection?Q37879600
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosisQ37880332
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarctionQ37880581
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.Q37880679
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouseQ37881023
Chronic Chlamydia pneumoniae infection and asthma exacerbations in childrenQ37881200
Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery diseaseQ37881317
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit modelQ37881464
Chronic infections and coronary heart disease: is there a link?Q37882245
Chlamydia pneumoniae and acute myocardial infarction in JerusalemQ37882349
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarctionQ37882420
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseQ37884972
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factorsQ37886448
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectChlamydia pneumoniaeQ62869737
P304page(s)1435-1439
P577publication date1999-11-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleCirculating Chlamydia pneumoniae DNA as a predictor of coronary artery disease
P478volume34

Reverse relations

cites work (P2860)
Q33968165Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells
Q24791856Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review
Q39365197Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory
Q37855685Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum
Q51726841Chlamydia pneumoniae and Cardiovascular Disease.
Q73311061Chlamydia pneumoniae and atherosclerosis
Q33905858Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies
Q35758705Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?
Q37865541Chlamydia pneumoniae in PBMC: reproducibility of the OMPA nested touchdown PCR.
Q35586029Chlamydia pneumoniae in infrequently examined blood vessels
Q35913303Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae
Q33971224Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography
Q37866926Comparison of five PCR assays for detecting Chlamydophila pneumoniae DNA.
Q43426679Coronary heart disease and Chlamydia pneumoniae DNA in blood mononuclear cells
Q37873684Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions
Q25255988Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques
Q34004325Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas
Q37873461Detection of Chlamydia pneumoniae antigenin PBMNCs of healthy blood donors
Q37871476Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls
Q37871627Detection of Chlamydia pneumoniae deoxyribonucleic acid in blood samples taken from coronary sinus after coronary angioplasty
Q34946766Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae
Q35538771Fibrinogen: biochemistry, epidemiology and determinants
Q37866783Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents
Q43426255Inflammation, infection and coronary artery disease: myths and realities. Special XXXV Conference of the National Congress of the Spanish Society of Cardiology
Q37869460Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study
Q37869059Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity
Q24531865PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids
Q33935030Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells
Q34465370Potential infectious etiologies of atherosclerosis: a multifactorial perspective
Q37872992Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease.
Q37866868Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors
Q37865613Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran
Q37870755Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols
Q37874322Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens
Q37864614Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients
Q34605356The role of infection in the genesis and complications of atherosclerosis